Related Experiment Videos
Upper extremity deep venous thrombosis
Aruna Kommareddy1, Michael H Zaroukian, Houria I Hassouna
1Department of Medicine, Michigan State University, East Lansing, Michigan 48824-1313, USA.
Seminars in Thrombosis and Hemostasis
|March 9, 2002
Summary
Upper extremity deep venous thrombosis (UEDVT) is uncommon but serious. Early detection and a multimodal treatment approach, including anticoagulation and thrombolysis, are crucial for reducing complications and improving patient outcomes.
Area of Science:
- Vascular Medicine
- Hematology
- Diagnostic Imaging
Background:
- Upper extremity deep venous thrombosis (UEDVT) accounts for 1-4% of all deep venous thrombosis (DVT) cases.
- Risk factors include central venous catheterization, anatomical compression, thrombophilia, and hypercoagulable states.
- UEDVT can be asymptomatic, necessitating a high index of suspicion in at-risk individuals.
Purpose of the Study:
- To review the risk factors, clinical presentations, and diagnostic methods for UEDVT.
- To discuss the evolving treatment strategies for UEDVT, moving towards a multimodal approach.
- To highlight the importance of early detection and management in preventing complications.
Main Methods:
- Literature review of UEDVT risk factors, clinical manifestations, and diagnostic modalities.
- Analysis of current and emerging treatment paradigms for UEDVT.
- Emphasis on compressive ultrasonography for diagnosis and multimodal therapy.
Main Results:
- Compressive ultrasonography is effective for diagnosing UEDVT.
- A multimodal treatment approach, including thrombolysis and anticoagulation, is increasingly favored over traditional anticoagulation alone.
- Low-dose anticoagulation can reduce UEDVT risk in patients with central venous catheters.
Conclusions:
- Prompt diagnosis and a comprehensive treatment strategy are essential for managing UEDVT.
- Multimodal therapy offers improved outcomes compared to traditional anticoagulation.
- Risk stratification and preventative measures are key in managing patients at risk for UEDVT.